Steering Committee

The 13 members of the OxCD3 Steering Committee, listed below, are responsible for managing funding flexibility and reviewing funding allocation to Work Packages in light of recent clinical and industrial developments and the recommendations of the IAB.

Chair
University of Oxford
Academic clinician - cancer radiology
University of Oxford
Professor of medical oncology
University of Surrey
Academic clinician - cancer surgery
University of Oxford
Academic Clinician - Oncology
National Institutes of Health
Industrial member
Dr Pavel Novak
Storz
Industrial member
OxSonics
Intellectual property representative
ISIS Innovation
Industrial member
Dr Richard Green
Pfizer
EPSRC Representative
Dr Matthew Weaver
Industrial member
Dr Marianne Ashford
AstraZeneca
       
Industry member
Dr Christopher van der Walle
MedImmune

 

© Copyright OXCD3 2016